User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 22 results.
    • Journal article
    Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.
    Perrot, Aurore Lauwers-Cances, Valerie Corre, Jill Robillard, Nelly Hulin, Cyrille Chretien, Marie-Lorraine Dejoie, Thomas Maheo, Sabrina Stoppa, Anne-Marie Pegourie, Brigitte Karlin, Lionel Garderet, Laurent Arnulf, Bertrand Doyen, Chantal[UCL] Meuleman, Nathalie Royer, Bruno Eveillard, Jean-Richard Benboubker, Lotfi Dib, Mamoun Decaux, Olivier Jaccard, Arnaud Belhadj, Karim Brechignac, Sabine Kolb, Brigitte Fohrer, Cecile Mohty, Mohamad Macro, Margaret Richardson, Paul G Carlton, Victoria Moorhead, Martin Willis, Tom Faham, Malek Anderson, Kenneth C Harousseau, Jean-Luc Leleu, Xavier Facon, Thierry Moreau, Philippe Attal, Michel Avet-Loiseau, Hervé Munshi, Nikhil (2018) Blood — Vol. 132, no. 23, p. 2456-2464 (2018)
    • Journal article
    Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
    Yakoub-Agha, Ibrahim Mary, Jean-Yves Hulin, Cyrille Doyen, Chantal Marit, Gérald Benboubker, Lotfi Voillat, Laurent Moreau, Philippe Berthou, Christian Stoppa, Anne-Marie Maloisel, Frédéric Rodon, Philippe Dib, Mamoun Pegourie, Brigitte Casassus, Philippe Slama, Borhane Damaj, Ghandi Zerbib, Robert Harousseau, Jean-Luc Mohty, Mohamad Facon, Thierry (2012) European journal of haematology — Vol. 88, no.3, p. 249-59 (2012)
    • Journal article
    Lenalidomide maintenance after stem-cell transplantation for multiple myeloma
    Attal, Michel Lauwers-Cances, Valerie Marit, Gerald Caillot, Denis Moreau, Philippe Facon, Thierry Stoppa, Anne Marie Hulin, Cyrille Benboubker, Lofti Garderet, Laurent Decaux, Olivier Leyvraz, Serge Vekemans, Marie-Christiane[UCL] Voillat, Laurent Michallet, Mauricette Pegourie, Brigitte Dumontet, Charles Roussel, Murielle Leleu, Xavier Mathiot, Claire Payen, Catherine Avet-Loiseau, Hervé Harousseau, Jean-Luc IFM Investigators Van Den Neste, Eric[UCL] (2012) New England Journal of Medicine — Vol. 366, no.19, p. 1782-1791 (2012)
    • Journal article
    Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
    Moreau, Philippe Attal, Michel Hulin, Cyrille Arnulf, Bertrand Belhadj, Karim Benboubker, Lotfi Béné, Marie C Broijl, Annemiek Caillon, Hélène Caillot, Denis Corre, Jill Delforge, Michel Dejoie, Thomas Doyen, Chantal[UCL] Facon, Thierry Sonntag, Cécile Fontan, Jean Garderet, Laurent Jie, Kon-Siong Karlin, Lionel Kuhnowski, Frédérique Lambert, Jérôme Leleu, Xavier Lenain, Pascal Macro, Margaret Mathiot, Claire Orsini-Piocelle, Frédérique Perrot, Aurore Stoppa, Anne-Marie van de Donk, Niels Wcj Wuilleme, Soraya Zweegman, Sonja Kolb, Brigitte Touzeau, Cyrille Roussel, Murielle Tiab, Mourad Marolleau, Jean-Pierre Meuleman, Nathalie Vekemans, Marie-Christiane[UCL] Westerman, Matthijs Klein, Saskia K Levin, Mark-David Fermand, Jean Paul Escoffre-Barbe, Martine Eveillard, Jean-Richard Garidi, Reda Ahmadi, Tahamtan Zhuang, Sen Chiu, Christopher Pei, Lixia de Boer, Carla Smith, Elena Deraedt, William Kampfenkel, Tobias Schecter, Jordan Vermeulen, Jessica Avet-Loiseau, Hervé Sonneveld, Pieter (2019) Lancet — Vol. 394, no. 10192, p. 29-38 (2019)
    • Journal article
    Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.
    Moreau, Philippe Attal, Michel Pégourié, Brigitte Planche, Lucie Hulin, Cyrille Facon, Thierry Stoppa, Anne-Marie Fuzibet, Jean-Gabriel Grosbois, Bernard Doyen, Chantal Ketterer, Nicolas Sebban, Catherine Kolb, Brigitte Chaleteix, Carine Dib, Mamoun Voillat, Laurent Fontan, Jean Garderet, Laurent Jaubert, Jérôme Mathiot, Claire Esseltine, Dixie Avet-Loiseau, Hervé Harousseau, Jean-Luc (2011) Blood — Vol. 117, no.11, p. 3041-4 (2011)
    • Journal article
    A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.
    Weisel, Katja Doyen, Chantal[UCL] Dimopoulos, Meletios Yee, Adrian Lahuerta, Juan José Martin, Amber Travers, Karin Druyts, Eric Toor, Kabirraaj Abildgaard, Niels Lu, Jin Van Droogenbroeck, Jan Geraldes, Catarina Petrini, Mario Voillat, Laurent Voog, Eric Facon, Thierry (2017) Leukemia and Lymphoma — Vol. 58, no. 1, p. 153-161 (2017)
    • Journal article
    Serum free light chains should be the target of response evaluation in light chain multiple myeloma rather than urines.
    Dejoie, Thomas Corre, Jill Caillon, Helene Hulin, Cyrille Perrot, Aurore Caillot, Denis Boyle, Eileen Chretien, Marie-Lorraine Fontan, Jean Belhadj, Karim Brechignac, Sabine Decaux, Olivier Voillat, Laurent Rodon, Philippe Fitoussi, Olivier Araujo, Carla Benboubker, Lotfi Fontan, Charlotte Tiab, Mourad Godmer, Pascal Luycx, Odile Allangba, Olivier Pignon, Jean-Michel Fuzibet, Jean-Gabriel Legros, Laurence Stoppa, Anne-Marie Dib, Mamoun Pegourie, Brigitte Orsini-Piocelle, Frederique Karlin, Lionel Arnulf, Bertrand Roussel, Murielle Garderet, Laurent Mohty, Mohamad Meuleman, Nathalie Doyen, Chantal[UCL] Lenain, Pascal Macro, Margaret Leleu, Xavier Facon, Thierry Moreau, Philippe Attal, Michel Avet-Loiseau, Herve (2016) Blood — Vol. 128, no. 25, p. 1941-2948 (2016)
    • Journal article
    Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial
    Facon, Thierry Doyen, Chantal[UCL] (2007) The Lancet — Vol. 370, no. 9594, p. 1209-1218 (2007)
    • Journal article
    Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy.
    Facon, Thierry Mary, Jean-Yves Pégourie, Brigitte Attal, Michel Renaud, Marc Sadoun, Alain Voillat, Laurent Dorvaux, Véronique Hulin, Cyrille Lepeu, Gérard Harousseau, Jean-Luc Eschard, Jean-Paul Ferrant, Augustin[UCL] Blanc, Michel Maloisel, Frédéric Orfeuvre, Hubert Rossi, Jean-François Azaïs, Isabelle Monconduit, Mathieu Collet, Philippe[UCL] Anglaret, Bruno Yakoub-Agha, Ibrahim Wetterwald, Marc Eghbali, Houchingue Vekemans, Marie-Christine Maisonneuve, Hervé Troncy, Jacques Grosbois, Bernard Doyen, Chantal[UCL] Thyss, Antoine Jaubert, Jérome Casassus, Philippe Thielemans, Béatrice Bataille, Régis (2006) Blood — Vol. 107, no. 4, p. 1292-8 (2006)
    • Journal article
    Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
    Moreau, Philippe Hulin, Cyrille Perrot, Aurore Arnulf, Bertrand Belhadj, Karim Benboubker, Lotfi Béné, Marie C Zweegman, Sonja Caillon, Hélène Caillot, Denis Corre, Jill Delforge, Michel Dejoie, Thomas Doyen, Chantal[UCL] Facon, Thierry Sonntag, Cécile Fontan, Jean Mohty, Mohamad Jie, Kon-Siong Karlin, Lionel Kuhnowski, Frédérique Lambert, Jérôme Leleu, Xavier Macro, Margaret Orsini-Piocelle, Frédérique Roussel, Murielle Stoppa, Anne-Marie van de Donk, Niels W C J Wuillème, Soraya Broijl, Annemiek Touzeau, Cyrille Tiab, Mourad Marolleau, Jean-Pierre Meuleman, Nathalie Vekemans, Marie-Christiane[UCL] Westerman, Matthijs Klein, Saskia K Levin, Mark-David Offner, Fritz Escoffre-Barbe, Martine Eveillard, Jean-Richard Garidi, Réda Ahmadi, Tahamtan Krevvata, Maria Zhang, Ke de Boer, Carla Vara, Sanjay Kampfenkel, Tobias Vanquickelberghe, Veronique Vermeulen, Jessica Avet-Loiseau, Hervé Sonneveld, Pieter (2021) The Lancet. Oncology — Vol. 22, no. 10, p. 1378-1390 (2021)
    • Journal article
    Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
    Harousseau, Jean-Luc Avet-Loiseau, Herve Attal, Michel Charbonnel, Catherine Garban, Frederic Hulin, Cyrille Michallet, Mauricette Facon, Thierry Garderet, Laurent Marit, Gerald Ketterer, Nicolas Lamy, Thierry Voillat, Laurent Guilhot, Francois Doyen, Chantal Mathiot, Claire Moreau, Philippe (2009) Journal of clinical oncology : official journal of the American Society of Clinical Oncology — Vol. 27, no.34, p. 5720-6 (2009)
    • Journal article
    Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
    Chari, Ajai Vogl, Dan T Gavriatopoulou, Maria Nooka, Ajay K Yee, Andrew J Huff, Carol A Moreau, Philippe Dingli, David Cole, Craig Lonial, Sagar Dimopoulos, Meletios Stewart, A Keith Richter, Joshua Vij, Ravi Tuchman, Sascha Raab, Marc S Weisel, Katja C Delforge, Michel Cornell, Robert F Kaminetzky, David Hoffman, James E Costa, Luciano J Parker, Terri L Levy, Moshe Schreder, Martin Meuleman, Nathalie Frenzel, Laurent Mohty, Mohamad Choquet, Sylvain Schiller, Gary Comenzo, Raymond L Engelhardt, Monika Illmer, Thomas Vlummens, Philip Doyen, Chantal[UCL] Facon, Thierry Karlin, Lionel Perrot, Aurore Podar, Klaus Kauffman, Michael G Shacham, Sharon Li, Lingling Tang, Shijie Picklesimer, Carla Saint-Martin, Jean-Richard Crochiere, Marsha Chang, Hua Parekh, Samir Landesman, Yosef Shah, Jatin Richardson, Paul G Jagannath, Sundar (2019) The New England journal of medicine — Vol. 381, no. 8, p. 727-738 (2019)
    • Journal article
    Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.
    Roussel, Murielle Lauwers-Cances, Valérie Macro, Margaret Leleu, Xavier Royer, Bruno Hulin, Cyrille Karlin, Lionel Perrot, Aurore Touzeau, Cyrille Chrétien, Marie-Lorraine Rigaudeau, Sophie Dib, Mamoun Nicolas-Virelizier, Emmanuelle Escoffre-Barbe, Martine Belhadj, Karim Mariette, Clara Stoppa, Anne-Marie Araujo, Carla Doyen, Chantal[UCL] Fontan, Jean Kolb, Brigitte Garderet, Laurent Brechignac, Sabine Malfuson, Jean-Valère Jaccard, Arnaud Lenain, Pascal Borel, Cécile Hebraud, Benjamin Benbrahim, Omar Dorvaux, Véronique Manier, Salomon Augeul-Meunier, Karine Vekemans, Marie-Christiane[UCL] Randriamalala, Edouard Chaoui, Driss Caers, Jo Chaleteix, Carine Benboubker, Lofti Vincent, Laure Glaisner, Sylvie Zunic, Patricia Slama, Borhane Eveillard, Jean-Richard Humbrecht-Kraut, Catherine Morel, Véronique Mineur, Philippe Eisenmann, Jean-Claude Demarquette, Hélène Richez, Valentine Vignon, Marguerite Caillot, Denis Facon, Thierry Moreau, Philippe Colin, Anne-Laurène Olivier, Pascale Wuilleme, Soraya Avet-Loiseau, Hervé Corre, Jill Attal, Michel (2022) Blood — Vol. 139, no. 18, p. 2747-2757 (2022)
    • Journal article
    Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma
    Attal, Michel Harousseau, Jean-Luc Leyvraz, Serge Doyen, Chantal Hulin, Cyrille Benboubker, Lofti Agha, Ibrahim Yakoub Bourhis, Jean-Henri Garderet, Laurent Pegourie, Brigitte Dumontet, Charles Renaud, Marc Voillat, Laurent Berthou, Christian Marit, Gerald Monconduit, Mathieu Caillot, Denis Grobois, Bernard Avet-Loiseau, Herve Moreau, Philippe Facon, Thierry (2006) Blood — Vol. 108, no. 10, p. 3289-3294 (2006)
    • Journal article
    Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
    Dimopoulos, Meletios A Moreau, Philippe Palumbo, Antonio Joshua, Douglas Pour, Ludek Hájek, Roman Facon, Thierry Ludwig, Heinz Oriol, Albert Goldschmidt, Hartmut Rosiñol, Laura Straub, Jan Suvorov, Aleksandr Araujo, Carla Rimashevskaya, Elena Pika, Tomas Gaidano, Gianluca Weisel, Katja Goranova-Marinova, Vesselina Schwarer, Anthony Minuk, Leonard Masszi, Tamás Karamanesht, Ievgenii Offidani, Massimo Hungria, Vania Spencer, Andrew Orlowski, Robert Z Gillenwater, Heidi H Mohamed, Nehal Feng, Shibao Chng, Wee-Joo ENDEAVOR Investigators[UCL] Vekemans, Marie-Christiane[UCL] Doyen, Chantal[UCL] (2016) The Lancet Oncology — Vol. 17, no. 1, p. 27-38 (2016)
    • Journal article
    Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
    Attal, Michel Harousseau, Jean-Luc Facon, Thierry Guilhot, François Doyen, Chantal[UCL] Fuzibet, Jean-Gabriel Monconduit, Mathieu Hulin, Cyrille Caillot, Denis Bouabdallah, Reda Voillat, Laurent Sotto, Jean-Jacques Grosbois, Bernard Bataille, Regis (2003) New England Journal of Medicine — Vol. 349, no. 26, p. 2495-2502 (2003)
    • Journal article
    Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
    Hulin, Cyrille Belch, Andrew Shustik, Chaim Petrucci, Maria Teresa Dührsen, Ulrich Lu, Jin Song, Kevin Rodon, Philippe Pégourié, Brigitte Garderet, Laurent Hunter, Hannah Azais, Isabelle Eek, Richard Gisslinger, Heinz Macro, Margaret Dakhil, Shaker Goncalves, Cristina LeBlanc, Richard Romeril, Ken Royer, Bruno Doyen, Chantal[UCL] Leleu, Xavier Offner, Fritz Leupin, Nicolas Houck, Vanessa Chen, Guang Ervin-Haynes, Annette Dimopoulos, Meletios A Facon, Thierry (2016) Journal of Clinical Oncology — Vol. 34, no. 30, p. 3609-3617 (2016)
    • Speech
    Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial
    Hulin, Cyrille Facon, Thierry Rodon, Philippe Pegourie, Brigitte Benboubker, Lotfi Doyen, Chantal Dib, Mamoun Guillerm, Gaelle Salles, Bruno Eschard, Jean-Paul Lenain, Pascal Casassus, Philippe Azais, Isabelle Decaux, Olivier Garderet, Laurent Mathiot, Claire Fontan, Jean Lafon, Ingrid Virion, Jean Marc Moreau, Philippe (2009) 49th Annual Meeting of the American-Society-of-Hematology — Atlanta(Ga)
    • Speech
    Bortezomib Plus Dexamethasone (VD)Versus Reduced-dose bortezomib Plus Thalidomide Plus Dexametasone (vTD) as Induction Treatment Prior to Autologous Stem-Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM)
    Harousseau, Jean-Luc Avet-Loiseau, Herve Facon, Thierry Attal, Michel Doyen, Chantal Hulin, Cyrille Garderet, Laurent Tiab, Mourad Lepeu, Gerard Aranjo, Christine Cailliot, Denis Petillon, Marie-Odile Mathiot, Claire Mary, Jean Yves Moreau, Philippe (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans(La)
    • Journal article
    Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.
    Moreau, Philippe Avet-Loiseau, Herve Facon, Thierry Attal, Michel Tiab, Mourad Hulin, Cyrille Doyen, Chantal (2011) Blood — Vol. 118, no. 22, p. 5752-5758; quiz 5982 (2011)
    • Journal article
    Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial.
    Boyle, Eileen M Leleu, Xavier Petillon, Marie-Odile Karlin, Lionel Doyen, Chantal[UCL] Demarquette, Hélène Royer, Bruno Macro, Margaret Moreau, Philippe Fostier, Karel Marie-Lorraine, Chretien Zarnitsky, Charles Perrot, Aurore Herbaux, Charles Poulain, Stephanie Manier, Salomon Beauvais, David Walker, Brian A Wardell, Christopher P Vincent, Laure Frenzel, Laurent Caillon, Hélène Susanna, Schraen Dejoie, Thomas Avet-Loiseau, Hervé Mohty, Mohamad Facon, Thierry IFM2014-04 investigators (2019) British journal of haematology — Vol. 187, no. 3, p. 319-327 (2019)
    • Speech
    Lenalidomide After Autologous Transplantation for Myeloma: First Analysis of a Prospective, Randomized Study of the Intergroupe Francophone Du Myelome (IFM 2005 02)
    Attal, Michel Harousseau, Jean Luc Marit, Gerald Caillot, Denis Stoppa, Anne Marie Benboubker, Lofti Facon, Thierry Hulin, Cyrille Garderet, Laurent Lamy, Thierry Leyvraz, Serge Doyen, Chantal Michallet, Mauricette Voillat, Laurent Dumonte, Charles Roussel, Murielle Lauwers-Cances, Vallery Cristini, Christelle Escriva, Chantal Petillon, Marie-Odile Mathiot, Claire Avet-Loiseau, Herve Moreau, Philippe (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans(La)